ANOTHER Irish woman is suing struck-off Italian plastic surgeon Marco Loiacono.
Papers were lodged in the latest case on the same day a cosmetic surgery clinic made an undisclosed settlement with former patient Kate Murray, who was left scarred for life after undergoing breast surgery carried out by the disgraced doctor.
The new personal injury case – over the alleged use of controversial PIP implants in breast augmentation surgery – is the 14th action taken against Mr Loiacono since 2009.
The 36-year-old surgeon was struck off the Medical Register in 2011 after he was found guilty of 14 counts of professional misconduct.
Ms Murray claimed that breast implant surgery carried out by Mr Loiacono left her in agony and she almost died from a subsequent infection.
Personal injury summons papers were filed with the High Court in the latest case on Wednesday.
Mr Loiacono is among four named defendants in the case being brought by a Dublin woman.
The papers allege Mr Loiacono acted negligently by using PIP implants in the surgery.
The woman claims that the implants became "tender and sore" in 2012 and that her GP advised her to undergo an MRI scan.
The woman is seeking damages for alleged personal injury and distress.
The other defendants are Clane Hospital, in Co Kildare, where the operation took place; UK-based Clover Leaf Products Ltd, which allegedly supplied the silicone implants; and the Irish Medicines Board, the agency that regulates medical devices such as implants.
Clane Hospital is one of three cosmetic surgery providers in Ireland that used PIP implants in some breast operations prior to the French-made product's recall in 2010.
The other clinics using the implants were Harley Medical Group in Dublin and Shandon Street Clinic in Cork.
Around 1,500 Irish women underwent breast surgery where PIP implants were used.
Nearly 140 have experienced ruptures in their implants, causing industrial-grade silicon more usually used to stuff mattresses to leak into their bodies.
Last night Clane Hospital's chief executive Sean Leyden declined to comment on the new legal action, saying he hadn't seen the papers, while Cloverleaf Medical did not respond to attempts to contact them.
A spokeswoman for the Irish Medicines Board said the agency "cannot comment on any ongoing legal actions".
Attempts to contact Mr Loiacono were unsuccessful.